Business
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as "Zydus") is an innovation-led life-sciences company with an international presence, today announced the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, and the exclusive Licensing Agreement with Agenus Inc. (NASDAQ: AGEN). This comprehensive closure follows the receipt of all the necessary regulatory approvals, including formal clearance from the Committee on Foreign Investme
About this update from Zydus Lifesciences Limited
[{"type":"text","content":"AHMEDABAD, India and PENNINGTON, N.J., Jan. 15, 2026 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as "Zydus") is an innovation-led life-sciences company with an international presence, today announced the successful closure of the Asset Purchase Agreement, Share Purchase Agreement, and the exclusive Licensing Agreement with Agenus Inc. (NASDAQ: AGEN). This comprehensive closure follows the receipt of all the necessary regulatory approvals, including formal clearance from the Committee on Foreign Investment in the United States ("CFIUS").","length":623,"tagName":"p"},{"type":"image","alt":"Zydus Lifesciences Limited","displaySize":"","headline":null,"caption":"Zydus Lifesciences Limited","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":231,"url":"https://media.zenfs.com/en/cnwgroup.com/2317ae45b512d46a7181d77c533d2419"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2.6B_tjdf2oNm5HDC3ytlw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQwNztjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/2317ae45b512d46a7181d77c533d2419","width":400,"height":231}}},{"type":"text","content":"The transaction establishes Zydus' advanced manufacturing facilities in the global biologics contract development and manufacturing organization ("CDMO") business. All acquired manufacturing assets and operations will be housed under a newly formed, dedicated U.S. based subsidiary named Zylidac Bio LLC.","length":323,"tagName":"p"},{"type":"text","content":"Commenting on the finalization of the deal, Dr. Sharvil P. Patel, Managing Director of Zydus Lifesciences Limited., stated, "With this deal, Zylidac Bio LLC will now provide biologicals manufacturing sites offering CDMO services to biopharmaceutical companies globally. This supports the evolving landscape of biological product manufacturing in the U.S., which prioritizes secure, domestic, and high-quality supply chains for advanced therapies. Zylidac Bio LLC offers a critical, compliant solution for global innovators and allows for a localized supply chain. It reinforces our ability to serve the international biopharmaceutical industry with reliability and innovation."","length":692,"tagName":"p"},{"type":"text","content":"Dr. Garo Armen, Chairman and CEO of Agenus,...